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Abstract
Background: Accurate information on the prevalence and causes of musculoskeletal impairment (MSI) is lacking in low
income countries. We present a new survey methodology that is based on sound epidemiological principles and is linked to
the World Health Organisation’s International Classification of Functioning.
Methods: Clusters were selected with probability proportionate to size. Households were selected within clusters through
compact segment sampling. 105 clusters of 80 people (all ages) were included. All participants were screened for MSI by a
physiotherapist and medical assistant. Possible cases plus a random sample of 10% of non-MSI cases were examined further
to ascertain diagnosis, aetiology, quality of life, and treatment needs.
Findings: 6757 of 8368 enumerated individuals (80.8%) were screened. There were 352 cases, giving an overall prevalence
for MSI of 5.2%. (95% CI 4.5–5.9) The prevalence of MSI increased with age and was similar in men and women.
Extrapolating these estimates, there are approximately 488,000 MSI diagnoses in Rwanda. Only 8.2% of MSI cases were
severe, while the majority were moderate (43.7%) or mild (46.3%). Diagnostic categories comprised 11.5% congenital, 31.3%
trauma, 3.8% infection, 9.0% neurological, and 44.4% non-traumatic non infective acquired. The most common individual
diagnoses were joint disease (13.3%), angular limb deformity (9.7%) and fracture mal- and non-union (7.2%). 96% of all cases
required further treatment.
Interpretation: This survey demonstrates a large burden of MSI in Rwanda, which is mostly untreated. The survey
methodology will be useful in other low income countries, to assist with planning services and monitoring trends.
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Introduction
There is a global lack of accurate information on the prevalence
and causes ofphysical disabilityinlow income countries [1,2]. There
are two main reasons for this deficiency. Firstly, there have not been
many surveys and secondly there is no universally accepted
definition of physical disability. The surveys that have been
undertaken have used a variety of definitions of physical disability,
and a range of methodologies for measuring disability so that
comparisons cannot be made between countries [3,4] . For example
one survey which asked detailed questions about difficulties in
different aspects of life, showed that Norway had a prevalence of
physical disability of 35% while the national census in India, which
merely asked whether there was a ‘‘physically handicapped’’ person
in the household estimated that the prevalence was 0.2% [5]. With
such different ways of measuring and defining disability there is little
benefit in making comparisons between countries, or over time
within a country. Where there has been a tighter definition of a
specific impairment or symptom such as has been used in the
COPCORD programme (Community-Oriented Program for the
Control of Rheumatic Diseases) [6] then it has been possible to
standardise a data collection methodology, with scope for interna-
tional comparison. The COPCORD programme is of great value in
comparing rheumatic and joint conditions in different countries,
however it does not include trauma or non painful congenital or
acquired musculoskeletal deformities.
The difficulty in defining physical disability stems from its many
anatomical, physiological and pathological presentations and
causes, and its intimate relation to society and the environment.
Terminology has also been confusing, and different groups in
society have different reasons for the varied used of the word
disability. This debate is of more than just academic interest as in
order to plan effective services it is important to estimate the
prevalence and causes of physical disability, which requires a
definition of the disability being measured and a survey
methodology. There have been many attempts to reach a common
understanding of disability, and the World Health Organisation’s
(WHO) publication of the International Classification on Func-
tioning (ICF) is a major step forward [7]. The ICF classifies
impairment of body structure and function, and also includes
domains that measure activity and participation in society.
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rehabilitation services and facilities for people with musculoskeletal
impairment (MSI) after its genocide and war of 1994 with all the
demographic and structural destruction that took place. In order to
plan effective services it is important to estimate the prevalence and
causes of MSI that exist inthe country.The WHO estimatesthat the
prevalence of all types of disability on a global level is around 10%
[8], but this estimate is of limited use for planning services in specific
situations. Realising this difficulty, Helander developed a ‘Rapid
Calculation ofDisability Prevalence’ for lessdeveloped regions of the
world and estimated that 4.8% of a population will need some
rehabilitation service [9]. Several physical disability surveys have
been conducted in Rwanda since the 1994 war, but all have their
limitations. Handicap International carried out a nationwide survey
in 1995 into ‘physical disability’ [10], and found a very low
prevalence of0.58%. Itsown researchers noted that thiswas low and
questioned whether many sections of the population might have
been inaccessible so soon after the war. A Community Based
Rehabilitation project in Kigali carried out a similar survey in 1997
and estimated that the prevalence was 1.8% (personal communica-
tion), but the sampling methodology was inadequate, and the
researchers believed that many households withheld information
about family members with physical disabilities.
In view of the lack of accurate data on the prevalence and
causes of MSI, we worked with the Ministry of Health of Rwanda
to develop a survey of MSI of all ages that involved a reliable
sampling methodology and a case definition and diagnostic criteria
that could clearly map onto the classification system used in the
ICF. Our aim was to develop a reliable survey tool that could be
used to plan and monitor MSI services in Rwanda and other
developing countries.
Methods
Sample selection – (see also diagram in Appendix S1)
The survey was designed to be nationally representative,
including people of all ages. The expected prevalence of MSI in
this group was estimated at approximately 3% [9,11]. Allowing for
a required confidence of 95%, a precision of 20%, a population
size of 8,441,000 in 2005 [11], a design effect of 2.3, and 15% non-
response, the required sample size was estimated to be 8399
subjects (Epi Info 6.04). In total, 105 clusters of 80 people were
needed for this survey. A cluster size of 80 people was chosen for
logistical reasons, as it was considered to be the number a team
could complete in one day.
A nationally representative sample of the population was
selected through cluster sampling with probability proportionate
to size. A list was produced of all the enumeration areas and their
respective populations, and a column was created with the
cumulative population across the settlements. The total population
(i.e. 8,441,000) was divided by the number of clusters required (i.e.
105) to derive the sampling interval (i.e. 80,390). The first cluster
was selected by multiplying the sampling interval with a random
number between 0 and 1. The resulting number was traced in the
cumulative population column and the first cluster was taken from
the corresponding enumeration area. The following clusters were
identified by adding the sampling interval to the previous number.
Households within clusters were selected through compact
segment sampling [12]. Maps of each selected cluster (i.e.
enumeration area) were obtained from the census bureau. These
maps included the locations of the head of ten-household
communities, thus showing approximate population distribution.
The enumeration area was visited two to three days before the
survey and the village leaders were asked to update the map. The
enumeration area was then divided into segments, so that each
segment included approximately 80 people. For instance, if an
enumeration area comprised 400 people then it would be divided
into five segments. One of the segments was chosen at random by
drawing lots and all households in the segment were included in the
sample sequentially until 80 people were identified. People were
eligible for inclusion if they lived in the household at least three
months of the year. All the individuals in the final household were
screened, and the number of people needed to complete the cluster
was randomly selected for inclusion (e.g. if the final household
included 5 people but only 3 were required to complete the cluster
then 3 out of the 5 were randomly selected for inclusion). If the
segment did not include 80 people then another segment was chosen
at random and sampling continued. If an eligible person was absent
the survey team returned to the household to examine him/her
before leaving the area. If after repeated visits the person could not
be examined, information about his/her presumed MSI status was
collected from relatives or neighbours.
Musculoskeletal impairment assessment
The fieldwork was carried out between October and December,
2005. The survey team visited households door-to-door and
conducted the MSI screening in the household. The survey team
consisted of a physiotherapist and an assistant, and they were
assisted in the clusters by a village guide, appointed by the village
leaders. The purpose of the study and the examination procedure
were explained to the subjects and verbal consent was obtained
before examination.
A standardised protocol was used for the screening and
assessment of MSI [13]. A survey record was filled for each
eligible person that included:
N Demographic information (all participants);
N A screening examination for MSI (all participants);
N A standardised interview and examination protocol for MSI
(cases and 10% random sample of non-cases)
N History of MSI (if not examined)
Screening for musculoskeletal impairment
The team physiotherapist screened all participants for MSI by
asking them seven questions about difficulties using their
musculoskeletal system, whether they used a mobility aid, whether
they felt they had any physical deformity, and how long they had
had these symptoms. Participants over 5 years of age were
questioned directly, while participants under 5 years were asked
through proxy, by the child’s main carer. Participants who
answered ‘‘yes’’ to any of the questions were classified as cases,
provided that the condition had lasted for more than one month or
was considered permanent. This screening tool was developed by
orthopaedic surgeons together with physiotherapists and has been
shown to have 99% sensitivity and 97% specificity with
interobserver Kappa scores of 0.90 for the diagnostic group [13].
Standardised interview and examination protocol
All cases were examined in more detail by the physiotherapist
using a standardised interview and examination protocol. A
random 10% sample of non-cases was also examined further, to
confirm their non-case status. The standardised examination
protocol assessed the aetiology, duration, severity, anatomical
location, diagnosis, and treatment, both received and required.
The standardised interview and examination protocol included
the following sections:
Rwanda Musculoskeletal Survey
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The physiotherapist observed the participant as they carried out
physical tasks that required use of the musculoskeletal system (i.e.
walking, crouching and upper limb motor skills)
b) Diagnosis
The physiotherapist categorized the diagnosis as: congenital,
traumatic, infective, neurological, or acquired non traumatic non
infective. Within these categories an algorithm was used to give a
specific diagnosis. Up to two diagnoses were permissible per
identified case of MSI [13].
c) Area affected and nature of problem
The physiotherapist recorded information on the area of the
body affected (e.g. arm) and the nature of the problem (e.g.
amputation).
d) Aetiology
Where this was known it was recorded. It was determined by
questioning the case about when the impairment developed and
how it came about. The physiotherapists were trained as to what
questions to ask for each aetiology available, which included road
traffic accidents, war, infection, and familial.
e) Severity
Severity was determined using ICF parameters for the amount
of function which has been lost through the presence of the MSI.
This was classified as ‘‘mild’’, ‘‘moderate’’ or ‘‘severe’’ [6].
f) EQ-5D
Generic quality of life was measured using the EQ-5D scale,
which is a public domain health-related quality of life question-
naire [14]. This was translated and back translated from English
into Kinyarwandan by two medical translators, independently of
each other. However, because of time restrictions, this was carried
out independently from the Euroqol group, and the translated
version of EQ-5D used in this study has therefore not been
approved by the Euroqol group
g) Treatment given
Current treatment received by the participant (if any) was
recorded.
h) Barriers to treatment
Cases were asked an open-ended question about why they had
not accessed treatment for their MSI. Up to four responses were
recorded per case on pre-coded forms.
i) Treatment needed
Treatment needed was assessed by the physiotherapist accord-
ing to standard protocols, appropriate for Rwanda.
Training and quality control
There were three teams, each consisted of a physiotherapist a
medical assistant, a village guide and a driver. The teams received
three weeks of training. Inter-observer agreement for case
definition, diagnosis, severity classification and treatment required
was assessed between the teams to ensure that it was of an
acceptable standard (i.e. kappa$0.60). A pilot survey was
undertaken of 480 people in 9 clusters (6 rural and 3 urban) to
assess examination process and procedures. During the main
survey, teams were accompanied by a field supervisor at least one
day per week, to ensure that a high quality was maintained. Each
day the supervisors checked items of all completed forms in the
field.
Statistical analysis
A database was constructed for data entry using EpiData 3.1.
The data were double-entered and validated, and inconsistencies
were checked. Stata 9.0 was used for analysis. The prevalence and
causes of MSI was estimated, taking into account the design effect
(DEFF) when estimating the confidence intervals. (see appendix S1
for details of estimation of DEFF)
Ethical approval
Ethical approval for this survey was granted by the Independent
Ethics Committee in Rwanda and the London School of Hygiene
& Tropical Medicine. Permission to proceed was granted by the
government, and consent was granted for each cluster visited from
the community leader at the province, district, sector and cell level.
Informed verbal consent was obtained from the subjects after
explanation of the nature and possible consequences of the study.
Written consent was obtained for any photographs that were
taken. All people with treatable MSI were referred to a central
community rehabilitation centre where clinical members of the
study team reviewed and referred the participants for further
treatment, as appropriate. The research followed the tenets of the
Declaration of Helsinki.
Role of funding source.
The funding for this study was provided by CBM international. One of the
authors (OR) was supported by Cure International. The funding organisations
played no part in, and had no influence on the design of the study, or the data,
collection, analysis or interpretation.
Results
Sampled population (table 1)
A total of 8368 individuals were enumerated and 6757 were
screened (Response rate=80.8%), 1596 (19.1%) were absent, 10
(0.1%) refused and 5(0.1%) were unable to communicate. The
response rate was higher in women (84.8%) than in men (76.3%).
Among the participants that were enumerated but not examined,
88 were believed to have MSI (5.5%). The age- and gender-
distribution of the sampled population was very similar to that of
the national population (Table 1).
Prevalence of MSI
Of the 6757 individuals screened there were 352 cases of MSI
giving an overall prevalence of MSI of 5.2% (CI 4.5–5.9) (Table 2).
The prevalence of MSI fell after early childhood and then
increased rapidly with age so that it was almost nine-fold higher in
people aged over 60 years compared to those aged 0–5 years
(OR=8.9, 6.0–13.4). The prevalence of MSI was similar in men
(5.1%) and women (5.3%). People in rural areas were more likely
to have an MSI (5.4%) than urban dwellers (4.1%), while those
without formal education were more likely to have an MSI (5.6%)
than those with formal education (4.5%), although these
associations disappeared after adjustment for age and gender.
Prevalence of MSI by Severity and Gender
The majority of cases of MSI were mild (47.1%) or moderate
(44.5%), and few were severe (8.4%) (Table 3). This pattern was
very similar in men and women.
MSI Diagnoses
There were a total of 390 diagnoses for 352 people with MSI
(Table 4). The most common causes of MSI were joint problems
(13.3% of MSI diagnoses), other acquired (12.3%), fracture non or
malunion (7.2%) and other chronic joint injury (6.2%). Overall 44%
of MSI were due to acquired non-traumatic non-infective causes,
31% due to trauma, 9% neurological were in origin, 4% due to
infection and 12% congenital. Extrapolating these estimates to the
total population of Rwanda there were 488,000 MSI diagnoses.
With increasing age, the prevalence of MSI increased rapidly
(Figure 1). The greatest proportional increase was in MSI diagnoses
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Congenital diagnoses were relatively more common in the youngest
age group than in older people and the proportion of neurological
diagnoses remained relatively constant with increasing age.
Aetiology of MSI
The aetiology of almost one third (32.1%) of the cases was
unknown. A further 28.1% were due to trauma, 15.1% due to
infection, 11.4% due to family history. Other aetiologies, including
Table 1. Age and gender composition of national* and screened sample population.
Age
Groups Male Female Total
49.7% 47% 44.3% 50.3% 52% 55.7%
National (%)
Enumerated
Sample
Screened
Sample (%) National (%)
Enumerated
Sample
S Screened
ample (%) National (%)
Enumerated
Sample
Screened
Sample (%)
0–10 1 302 000 (31.1) 1394 (35.4) 1222 (40.7) 1 287 000 (30.3) 1420 (32.1) 1295 (34.5) 2 589 000 (30.7) 2816 (33.7) 2519 (37.3)
11–20 964 000 (23.0) 1029 (26.2) 723 (24.1) 964 000 (22.7) 1081 (24.4) 832 (22.2) 1 929 000 (22.9) 2116 (25.3) 1559 (23.1)
21–30 807 000 (19.2) 601 (15.3) 386 (12.9) 808 000 (19.0) 724 (16.4) 567 (15.1) 1 616 000(19.1) 1325 (15.8) 953 (14.1)
31–40 482 000 (11.5) 335 (8.5) 234 (7.8) 467 000 (11.0) 422 (9.5) 358 (9.5) 949 000 (11.2) 757 (9.1) 592 (8.8)
41–50 326 000(7.7) 275 (7.0) 195 (6.5) 327 000 (7.7) 330 (7.5) 292 (7.8) 654 000 (7.7) 605 (7.2) 487 (7.2)
51–60 182 000(4.3) 160 (4.1) 126 (4.2) 205 000 (4.8) 231 (5.2) 203 (5.4) 387 000 (4.6) 392 (4.69) 329 (4.9)
.60 129 000 (3.1) 140 (3.6) 114 (3.8) 190 000 (4.5) 216 (4.9) 204 (5.4) 289 000 (3.4) 356 (4.3) 318 (4.7)
Total 4 193 000
(100.0)
3934 (100.0) 3000 (100.0) 4 248 000
(100.0)
4424 (100.0) 3751 (100.0) 8 441 000
(100.0)
8367 (100.0) 6757
$ (100.0)
*based on us census bureau data for Rwanda population 2005 as this has age group divisions
$missing gender data for 6 individuals
doi:10.1371/journal.pone.0002851.t001
Table 2. Prevalence of MSI by age, gender, location and educational level of head of household.
Categories
*
total no
screened.
No of MSI cases
in that group
Prevalence of MSI
(95% CI)
Age and sex adjusted
Odds Ratios (95%CI)
Total 6757 352 5.2% (4.5–5.9%)
Age groups 0–5 years 1520 52 3.4% (2.3–4.5%) 1
6–16 years 2006 39 1.9% (1.2–2.7%) 0.6 ( 0.4–0.9)
17–60 years 2913 185 6.4% (5.3–7.4%) 1.9 (1.4–2.7)
.60 years 318 76 23.9% (18.5–29.3%) 8.9 (6.0–13.4)
Gender Male 3000 153 5.1% (4.3–6.0%) 1
Female 3751 199 5.3% (4.5–6.2%) 0.9 (0.8–1.2)
Location Rural 5806 312 5.4% (4.6–6.1%) 1
Urban 938 39 4.1% (2.7–5.6%) 0.9 (0.6–1.4)
Educational Level of Head of household No formal education 4346 244 5.6% (4.8–6.5%) 1
Formal education 2399 108 4.5% (3.5–5.5%) 0.9 (0.7–1.2)
*There were some missing values
doi:10.1371/journal.pone.0002851.t002
Table 3. Distribution of MSI according to severity and gender, and its association with quality of life.
Male Female Total
MSI status Number
Proportion of
MSI cases Number
Proportion of
MSI cases Number
Proportion of
MSI cases
EQ-5D VAS Score
(95% CI)
Mild MSI 69 46.0% 94 48.0% 163 47.1% 44.4 (40.5–47.8)
Moderate MSI 65 43.3% 89 45.4% 154 44.5% 37.7.(35.4–40.0)
Severe MSI 16 10.7% 13 6.6% 29 8.4% 16.9 (11.7–22.0)
No MSI 2847 3552 6399 63.1 (61.4–64.7)
doi:10.1371/journal.pone.0002851.t003
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perinatal hypoxia (0.3%) were relatively rare.
Quality of life
The mean quality of life score was significantly higher in people
without MSI (63.1, 95%CI 61.4–64.7) than among the cases (37.7,
35.4–40.0, p value,0.001. Severe cases had significantly poorer
quality of life (16.9, 11.7–22.0) than moderate (34.9, 31.8–38.0),
and mild cases (44.0, 40.5–47.8) (p-value 0.003).
Treatment needed
In total, 641 treatments were needed for the 390 diagnoses
(table 5). The most common treatments needed were physical
therapy (44.5%), surgery (22.9%) or medication (16.1%). Extrap-
Table 4. Cause of MSI in survey, and extrapolated to population of Rwanda.
Diagnosis Number Total in category (%)
Extrapolated number of that diagnostic
category in Rwanda to nearest 1000 (95%CI)
A Congenital deformity 45 (12%) 59,000 (95% CI 39,000–74,000)
Polydactyly 16
Syndactyly 2
Other upper limb deformity 4
Club foot 4
Other lower limb deformity 12
Spine deformity 1
Cleft lip or cleft palate 2
Multiple abnormalities 2
Other congenital deformity 2
B Trauma 122 (31%) 156,000 (95% CI 125,000–187,000)
Fracture non or malunion 28
Burn contracture 4
Spine injury 3
Head injury 3
Joint chronic dislocation 6
Other chronic joint injury 24
Tendon, muscle or nerve injury 12
Amputation 20
Other traumatic MSI 22
C Infective 15 (4%) 20,000 (95% CI 9,000–29,000)
Joint infection 4
Bone infection limb 8
Bone infection spine 1
Skin/soft tissue infection/wound 2
D Neurological 35 (9%) 44,000 (95% CI 27,000–60,000)
Polio 8
Para/quadri/tetraplegia 11
Cerebral palsy or developmental delay 5
Peripheral nerve palsy 4
Other neurological MSI 7
E Other acquired non-traumatic non-infective 173 (44%) 216,000 (95% CI 182,000–245,000)
Joint problem 52
Angular limb deformity 38
Skin/soft tissue tumour/swelling 12
Spine deformity 2
Spine pain 11
Limb pain 5
Limb swelling 5
Other acquired 48
TOTAL 390 488,000
doi:10.1371/journal.pone.0002851.t004
Rwanda Musculoskeletal Survey
PLoS ONE | www.plosone.org 5 August 2008 | Volume 3 | Issue 7 | e2851olating these estimates to the entire Rwandese population,
approximately 814,000 treatments are required, including
356,000 courses of physical therapy, 184,000 operations and
129,000 courses of medicine.
Discussion
This study estimates that the prevalence of MSI in Rwanda is
5.2% (95% CI 4.5–5.9). The prevalence of MSI is similar in men
and women, but is much higher in older people as a result of an
increase in cases caused by trauma, and degenerative changes
(classified under the category ‘ acquired non traumatic non
infective causes’), that are more prevalent in this age group. The
overall prevalence for the population is higher than might be
expected when compared to previous studies in Rwanda, but is in
line with expectations of WHO and other prevalence estimations
for other countries in the region [8,9]. In addition to comparisons
with other historical surveys and estimations, the accuracy of this
survey can be measured against studies of common congenital
abnormalities such as club foot. In this case the measured
prevalence of 0.07% for club foot is consistent with an incidence of
around 1 in 1000 live births as has been measured in other
international studies [15].
53% of cases of MSI were moderate or severe according to the
ICF classification, thus they significantly affect the life of the
individuals concerned and their communities, and will have
implications for the development of rehabilitation and other
services in Rwanda.
The survey has produced results that will be of use in planning
rehabilitation and other services in Rwanda. For example good
estimations can be drawn as to the need for appliances, orthoses,
prostheses and wheelchairs. This knowledge of need can be used as
a target for production and supply of these items. Similarly
accurate estimations of the need for medical services such as
physiotherapy and surgery can be used to measure the capacity of
Figure 1. Prevalence and diagnostic categories of MSI, by age group.
doi:10.1371/journal.pone.0002851.g001
Table 5. Treatment needed among cases with MSI in survey,
and extrapolated to population of Rwanda.
Treatment
modality
Number of cases
in survey needing
that treatment
modality
Extrapolated number in country
needing that treatment
modality (based on 2005
population estimates) (95% CI)
Medication 103 132,000 (104,000–159,000)
POP / Splintage 53 68,000 (44,000–91,000)
Physical therapy 285 362,000 (340,000–383,000)
Mobility aid 12 15,000 (6,000–25,000)
Appliance 6 8,000 (2,000–14,000)
Orthosis 16 21,000 (10,000–30,000)
Prosthesis 5 6,000 (1,000–12,000)
Wheelchair 8 10,000 (3,000–17,000)
Surgery 147 187,000 (162,000–212,000)
Permanent care 6 5,000 (0–10,000)
TOTAL 641 814,000
doi:10.1371/journal.pone.0002851.t005
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provision. The estimations can be used to plan both building of
medical facilities, and training of personnel such as physical
therapists, orthotists, prosthetists, clinicians and surgeons, to treat
the burden of musculoskeletal impairment.
Some MSIs are potentially preventable, in particular those
involving trauma, and to a lesser extent infection. This survey was
not intended to show how such prevention might be carried out,
but it helps in planning as it gives an indication of the reduction in
overall burden of disability in the community if particular MSIs
can be prevented or at least reduced.
The study had many strengths, which lend confidence to the
estimates obtained. A major strength is that a nationally
representative sample of people of all ages was enumerated and
examined. There is unlikely to have been serious selection bias, as
the response rate was high and the sample was representative of
the national population in terms of age- and sex- distribution.
Furthermore, the reported prevalence of MSI among the sample
and non-responders was very similar at 5.2% and 5.5%
respectively. Information bias was also unlikely as outcome
definition was undertaken by experienced physiotherapists, using
a sensitive screening tool [13], and a robust questionnaire and
examination protocol. There was good inter-observer agreement
between the examiners and sensitivity and specificity of diagnosis
was high. Furthermore, the specific diagnoses of MSI could be
mapped on to ICF impairment categories for comparison with
other ICF linked studies. The survey methodology was practical
for use in a low-income country after a relatively short in-country
training programme.
There were also limitations to the study. Since the examinations
were carried out door-to-door, the diagnostic tools were limited to
history and a clinical examination. It is also intentionally limited to
MSI and does not give an estimate of other areas of impairment
such as blindness, deafness or mental impairment. The in-country
study costs were in the region of $100,000 and this may limit its
use in other low income countries. This sum may seem high, but it
reflects the real costs in mobilising a local survey team and giving
logistic support over two months.
In conclusion, this survey demonstrates a large burden of MSI
in Rwanda, which is mostly untreated. The demonstrated need
will be useful in planning services. The survey methodology will
also be useful in other low income countries.
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